Advertisement
Screener

MiMedx Group, Inc. (MDXG) Share-based Payment Arrangement, Decrease for Tax Withholding Obligation

MiMedx Group, Inc. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation

MiMedx Group, Inc. (MDXG) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $2.60 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.

Financial Statements › Notes › Stockholders' Equity Note

us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2025-02-26

  • MiMedx Group, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-12-31 was -$1.00K.
  • MiMedx Group, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
  • MiMedx Group, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
  • MiMedx Group, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-03-31 was $1.19M, a 62.97% decline year-over-year.
  • MiMedx Group, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $2.60M.
  • MiMedx Group, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • MiMedx Group, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $1.19M, a 74.95% decline from fiscal 2021.
  • MiMedx Group, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2021 was $4.75M, a 103.56% increase from fiscal 2020.
Period endShare-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 monthShare-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 monthShare-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 monthShare-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month as first filedShare-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month
2024-12-31$2.60M
10-K · filed 2025-02-26
2023-12-31$0.00
10-K · filed 2025-02-26
2022-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
-$1.00K
derived: sum of 2 quarters · filed 2025-02-26
-$1.00K
derived: sum of 3 quarters · filed 2025-02-26
$1.19M
10-K · filed 2025-02-26
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30
$0.00
derived: sum of 2 quarters · filed 2023-10-30
$1.19M
10-Q · filed 2023-10-30
$1.19M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$1.19M
10-Q · filed 2023-08-01
$1.19M
derived: sum of 3 quarters · filed 2024-02-28
$1.38M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$1.19M
10-Q · filed 2023-05-02
$1.19M
derived: sum of 2 quarters · filed 2024-02-28
$1.38M
derived: sum of 3 quarters · filed 2024-02-28
$2.73M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$188.00K
derived: sum of 2 quarters · filed 2024-02-28
$1.53M
derived: sum of 3 quarters · filed 2024-02-28
$4.75M
10-K · filed 2024-02-28
2021-09-30$188.00K
10-Q · filed 2022-11-02
$1.53M
derived: sum of 2 quarters · filed 2022-11-02
$4.75M
10-Q · filed 2022-11-02
$4.68M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$1.35M
10-Q · filed 2022-08-02
$4.56M
10-Q · filed 2022-08-02
$4.49M
derived: sum of 3 quarters · filed 2023-02-28
$4.57M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$3.22M
10-Q · filed 2022-05-03
$3.14M
derived: sum of 2 quarters · filed 2023-02-28
$3.22M
derived: sum of 3 quarters · filed 2023-02-28
$4.10M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$75.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$4.00K
derived: sum of 2 quarters · filed 2023-02-28
$883.00K
derived: sum of 3 quarters · filed 2023-02-28
$2.33M
10-K · filed 2023-02-28
2020-09-30$79.00K
10-Q · filed 2021-11-02
$958.00K
derived: sum of 2 quarters · filed 2021-11-02
$2.41M
10-Q · filed 2021-11-02
$2.60M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$879.00K
10-Q · filed 2021-08-03
$2.33M
10-Q · filed 2021-08-03
$2.52M
derived: sum of 3 quarters · filed 2022-02-28
$2.69M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$1.45M
10-Q · filed 2021-04-28
$1.64M
derived: sum of 2 quarters · filed 2022-02-28
$1.82M
derived: sum of 3 quarters · filed 2022-02-28
$1.88M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$192.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$365.00K
derived: sum of 2 quarters · filed 2022-02-28
$430.00K
derived: sum of 3 quarters · filed 2022-02-28
$1.47M
10-K · filed 2022-02-28
2019-09-30$173.00K
10-Q · filed 2020-11-04
$238.00K
derived: sum of 2 quarters · filed 2020-11-04
$1.28M
10-Q · filed 2020-11-04
$1.28M
10-Q · filed 2020-07-06
$1.57M
derived: sum of 4 quarters · filed 2021-03-08
2019-06-30$65.00K
10-Q · filed 2020-08-04
$1.11M
10-Q · filed 2020-08-04
$1.39M
derived: sum of 3 quarters · filed 2021-03-08
$1.62M
derived: sum of 4 quarters · filed 2021-03-08
2019-03-31$1.04M
10-Q · filed 2020-07-06
$1.33M
derived: sum of 2 quarters · filed 2021-03-08
$1.55M
derived: sum of 3 quarters · filed 2021-03-08
$1.89M
derived: sum of 4 quarters · filed 2021-03-08
2018-12-31$285.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08
$510.00K
derived: sum of 2 quarters · filed 2021-03-08
$841.00K
derived: sum of 3 quarters · filed 2021-03-08
$4.91M
10-K · filed 2021-03-08
2018-09-30$225.00K
10-Q · filed 2020-07-06
$556.00K
derived: sum of 2 quarters · filed 2020-07-06
$4.63M
10-Q · filed 2020-07-06
$5.37M
derived: sum of 4 quarters · filed 2020-07-06
2018-06-30$331.00K
10-Q · filed 2020-07-06
$4.40M
10-Q · filed 2020-07-06
$5.15M
derived: sum of 3 quarters · filed 2020-07-06
$5.82M
derived: sum of 4 quarters · filed 2020-07-06
2018-03-31$4.07M
10-Q · filed 2020-07-06
$4.82M
derived: sum of 2 quarters · filed 2020-07-06
$5.49M
derived: sum of 3 quarters · filed 2020-07-06
$5.83M
derived: sum of 4 quarters · filed 2020-07-06
2017-12-31$745.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-06
$1.42M
derived: sum of 2 quarters · filed 2020-07-06
$1.75M
derived: sum of 3 quarters · filed 2020-07-06
$4.08M
10-K · filed 2020-07-06
2017-09-30$671.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$1.01M
derived: sum of 2 quarters · filed 2017-10-31
$3.34M
10-Q · filed 2017-10-31
$3.61M
derived: sum of 4 quarters · filed 2020-03-17
2017-06-30$339.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31
$2.67M
10-Q · filed 2017-07-31
$2.94M
derived: sum of 3 quarters · filed 2020-03-17
$3.15M
derived: sum of 4 quarters · filed 2020-03-17
2017-03-31$2.33M
10-Q · filed 2017-05-01
$2.60M
derived: sum of 2 quarters · filed 2020-03-17
$2.81M
derived: sum of 3 quarters · filed 2020-03-17
$2.81M
derived: sum of 4 quarters · filed 2020-03-17
2016-12-31$273.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17
$481.00K
derived: sum of 2 quarters · filed 2020-03-17
$481.00K
derived: sum of 3 quarters · filed 2020-03-17
$1.17M
10-K · filed 2020-03-17
2016-09-30$208.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
$208.00K
derived: sum of 2 quarters · filed 2016-11-08
$892.00K
10-Q · filed 2016-11-08
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02
$684.00K
10-Q · filed 2016-08-02
2016-03-31$684.00K
10-Q · filed 2016-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
SpyGlass Pharma, Inc. (SGP)United States$0.925B